CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 38 enrolled
Drug / intervention
lidocaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01515540
NCT01515540Phase 4Completed
CompareCT.gov

Brain Imaging of Lidoderm for Chronic Back Pain

Northwestern University·interventional·Posted Jan 24, 2012·Updated Jul 30, 2013

In Brief

A Phase 4 clinical trial evaluating lidocaine and placebo for Low Back Pain. Completed, enrolled 38 participants across 1 site.

Detailed Summary

The investigators tested whether pain decrease can be observed centrally with non-invasive brain imaging in CBP subjects receiving Lidoderm. The investigators first tested effects of 5% Lidoderm patched in an open labelled trial. Next the investigators compared the effects of Lidocaine versus Placebo patches. Three time points were evaluated: baseline (before treatment) and 6 hours and 2 weeks after treatment. The latter trial was a 2 arm, double blind, placebo controlled trial, where participants either received Lidoderm or placebo patches, without cross over.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLow Back Pain
CountriesUnited States
CollaboratorsEndo Pharmaceuticals

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 24, 2012
Enrollment StartJan 1, 2004
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 14.4 years ago

Interventions

lidocainedrug

5% lidoderm patch

placebodrug

placebo